Reduced levels of TUDCA, a key hydrophilic bile acid, may disrupt cholesterol metabolism and promote intrahepatic cholestasis by impairing the Farnesoid X receptor (FXR) signaling pathway, thereby exacerbating hepatotoxicity [47]. Here, NR1H4 is linked to cholestasis.